Vaccine keeps advanced kidney cancer from recurring

Health Rounds: Vaccine keeps advanced kidney cancer from recurring
Patients with advanced kidney cancer who received an experimental vaccine after their tumors were removed were still cancer-free years later in a small
Cancer vaccine prevents recurrence of advanced kidney cancer in small trial
After their advanced kidney tumors were surgically removed, nine patients were protected from the cancer returning thanks to an experimental, personalized cancer vaccine, researchers reported Feb. 5.
Experimental vaccine seems to battle advanced kidney cancers
A small, early trial of a vaccine that mobilizes the immune system to battle advanced kidney cancers appears successful, researchers report.
Promising Cancer Vaccine Boosts Hope for Stage III and IV Kidney Cancer
All patients involved in the phase 1 trial of a personalized cancer vaccine for high-risk stage III/IV kidney cancer showed a successful anticancer immune response.
New Vaccine Shows Promise For Kidney Cancer
A new vaccine for kidney cancer shows excellent preliminary results. All patients on the trial had no evidence of cancer three years after the pioneering treatment.
Personalized cancer vaccine shows potential in kidney cancer
In a Phase 1 study, nine people with advanced kidney cancer became cancer free after receiving personalized vaccines.
Personalized vaccine offers hope for patients with late-stage kidney cancer, clinical trial shows
Cancer researchers are one step closer to developing an effective vaccine to treat people with clear cell renal cell carcinoma (ccRCC), the most common type of kidney cancer among adults. In an early-stage clinical trial led by the Dana-Farber Cancer Institute in Boston,
Personalized vaccines halt kidney cancer after encouraging phase 1 trial
In a nutshell Researchers developed personalized cancer vaccines for nine high-risk kidney cancer patients, with all participants remaining cancer-free after nearly three years of follow-up – a significant advancement for a cancer type that traditionally has limited treatment options.
'Exciting' cancer vaccine offers hope for patients
Lesley Jenkins had surgery to remove a tumour that was discovered following a routine bowel test.
Fact Check: Moderna began clinical trials of COVID vaccine in 2020, not 2017
Data on mRNA vaccines sent by Moderna to European regulators before the COVID-19 outbreak included early tests of the mRNA ...
Three Years After Experimental Vaccine, These Patients Are Still Cancer-Free
An experimental vaccine for kidney cancer is off to a promising start. In data from a Phase I trial released this week, the ...
Medscape21h
HPV Vaccine ‘Very Promising’ for Nixing Precancerous Lesions
A new HPV vaccine induced regression of precancerous cervical lesions in 50% of patients and led to viral clearance in some ...
The Independent on MSN11d
Cancer vaccine being created by UK scientists could stop disease up to 20 years early
A new partnership between the University of Oxford and GSK aims to develop vaccines against cancer before develop ...
News Medical on MSN1d
Neoantigen vaccine sparks powerful immune defense against kidney cancer
A personalized neoantigen cancer vaccine generated strong immune responses in renal cell carcinoma patients, leading to ...
Medscape1d
Personalized Neoantigen Vaccine Shows Promise in High-Risk Renal Cell Carcinoma
Researchers evaluated a neoantigen-targeting personalized cancer vaccine in patients with high-risk, fully resected clear ...
500 underprivileged girls in Bengaluru receive free HPV vaccines to prevent cervical cancer: Report
In a bid to tackle cervical cancer, one of the leading causes of cancer-related deaths among women, 500 adolescent girls from ...